XBIOTECH INC. Operating Expenses
XBIOTECH INC. (XBIT) reported Operating Expenses of $6.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- XBIOTECH INC. operating expenses for the quarter ending 2026-06-30 was $6.15M, a 3.00% decline year-over-year.
- XBIOTECH INC. operating expenses for the quarter ending 2025-09-30 was $6.05M, a 23.49% decline year-over-year.
- XBIOTECH INC. operating expenses for the quarter ending 2025-06-30 was $6.34M, a 57.66% decline year-over-year.
- XBIOTECH INC. operating expenses for the quarter ending 2025-03-31 was $13.55M, a 24.85% increase year-over-year.
- XBIOTECH INC. operating expenses for fiscal 2024 was $42.47M, a 13.23% increase from fiscal 2023.
- XBIOTECH INC. operating expenses for fiscal 2023 was $37.51M, a 0.90% decline from fiscal 2022.
- XBIOTECH INC. operating expenses for fiscal 2022 was $37.85M, a 0.51% increase from fiscal 2021.
- XBIOTECH INC. operating expenses for fiscal 2021 was $37.66M, a 35.82% increase from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $6.15M 10-Q · filed 2026-08-13 | $12.42M 10-Q · filed 2026-08-13 | |||
| 2025-09-30 | $6.05M 10-Q · filed 2025-11-12 | $12.38M derived: sum of 2 quarters · filed 2026-08-13 | $25.93M 10-Q · filed 2025-11-12 | $34.68M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $6.34M 10-Q · filed 2026-08-13 | $19.89M 10-Q · filed 2026-08-13 | $28.63M derived: sum of 3 quarters · filed 2026-08-13 | $36.54M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $13.55M 10-Q · filed 2026-05-14 | $22.30M derived: sum of 2 quarters · filed 2026-05-14 | $30.20M derived: sum of 3 quarters · filed 2026-05-14 | $45.17M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $8.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $16.65M derived: sum of 2 quarters · filed 2026-03-13 | $31.62M derived: sum of 3 quarters · filed 2026-03-13 | $42.47M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $7.90M 10-Q · filed 2025-11-12 | $22.87M derived: sum of 2 quarters · filed 2025-11-12 | $33.72M 10-Q · filed 2025-11-12 | $42.31M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $14.97M 10-Q · filed 2025-08-13 | $25.82M 10-Q · filed 2025-08-13 | $34.41M derived: sum of 3 quarters · filed 2025-08-13 | $42.93M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $10.85M 10-Q · filed 2025-05-14 | $19.44M derived: sum of 2 quarters · filed 2025-05-14 | $27.96M derived: sum of 3 quarters · filed 2025-05-14 | $41.22M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $8.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $17.11M derived: sum of 2 quarters · filed 2025-03-18 | $30.36M derived: sum of 3 quarters · filed 2025-03-18 | $37.51M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $8.52M 10-Q · filed 2024-11-13 | $21.78M derived: sum of 2 quarters · filed 2024-11-13 | $28.92M 10-Q · filed 2024-11-13 | $37.37M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $13.26M 10-Q · filed 2024-08-12 | $20.40M 10-Q · filed 2024-08-12 | $28.85M derived: sum of 3 quarters · filed 2024-08-12 | $36.70M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $7.14M 10-Q · filed 2024-05-10 | $15.59M derived: sum of 2 quarters · filed 2024-05-10 | $23.45M derived: sum of 3 quarters · filed 2024-05-10 | $36.86M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $16.30M derived: sum of 2 quarters · filed 2024-03-15 | $29.72M derived: sum of 3 quarters · filed 2024-03-15 | $37.85M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $7.85M 10-Q · filed 2023-11-09 | $21.27M derived: sum of 2 quarters · filed 2023-11-09 | $29.40M 10-Q · filed 2023-11-09 | $40.05M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $13.42M 10-Q · filed 2023-08-11 | $21.55M 10-Q · filed 2023-08-11 | $32.20M derived: sum of 3 quarters · filed 2023-08-11 | $39.34M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $8.13M 10-Q · filed 2023-05-10 | $18.78M derived: sum of 2 quarters · filed 2023-05-10 | $25.92M derived: sum of 3 quarters · filed 2023-05-10 | $39.69M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $10.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $17.79M derived: sum of 2 quarters · filed 2023-03-15 | $31.56M derived: sum of 3 quarters · filed 2023-03-15 | $37.66M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $7.14M 10-Q · filed 2022-11-09 | $7.14M 10-Q · filed 2021-11-09 | $20.91M derived: sum of 2 quarters · filed 2022-11-09 | $27.01M 10-Q · filed 2022-11-09 | $34.95M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $13.77M 10-Q · filed 2022-08-10 | $19.87M 10-Q · filed 2022-08-10 | $27.81M derived: sum of 3 quarters · filed 2022-08-10 | $33.60M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $6.10M 10-Q · filed 2022-05-10 | $14.04M derived: sum of 2 quarters · filed 2022-05-10 | $19.84M derived: sum of 3 quarters · filed 2022-05-10 | $28.65M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $7.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $13.74M derived: sum of 2 quarters · filed 2022-03-15 | $22.55M derived: sum of 3 quarters · filed 2022-03-15 | $27.73M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $5.79M 10-Q · filed 2021-11-09 | $14.60M derived: sum of 2 quarters · filed 2021-11-09 | $19.78M 10-Q · filed 2021-11-09 | $33.09M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-06-30 | $8.81M 10-Q · filed 2021-08-09 | $13.99M 10-Q · filed 2021-08-09 | $27.30M derived: sum of 3 quarters · filed 2022-03-15 | $33.41M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-03-31 | $5.18M 10-Q · filed 2021-05-10 | $18.49M derived: sum of 2 quarters · filed 2022-03-15 | $24.60M derived: sum of 3 quarters · filed 2022-03-15 | $30.61M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2019-12-31 | $13.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $19.42M derived: sum of 2 quarters · filed 2022-03-15 | $25.43M derived: sum of 3 quarters · filed 2022-03-15 | $31.23M 10-K · filed 2022-03-15 | |
| 2019-09-30 | $6.11M 10-Q · filed 2020-11-09 | $12.12M derived: sum of 2 quarters · filed 2020-11-09 | $17.92M 10-Q · filed 2020-11-09 | $24.03M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-06-30 | $6.01M 10-Q · filed 2020-08-10 | $11.81M 10-Q · filed 2020-08-10 | $17.92M derived: sum of 3 quarters · filed 2021-03-16 | $23.03M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-03-31 | $5.80M 10-Q · filed 2020-05-11 | $11.91M derived: sum of 2 quarters · filed 2021-03-16 | $17.03M derived: sum of 3 quarters · filed 2021-03-16 | $22.65M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-12-31 | $6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $11.22M derived: sum of 2 quarters · filed 2021-03-16 | $16.84M derived: sum of 3 quarters · filed 2021-03-16 | $20.99M 10-K · filed 2021-03-16 | |
| 2018-09-30 | $5.12M 10-Q · filed 2019-11-12 | $10.74M derived: sum of 2 quarters · filed 2019-11-12 | $14.89M 10-Q · filed 2019-11-12 | $22.39M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | $5.62M 10-Q · filed 2019-08-09 | $9.77M 10-Q · filed 2019-08-09 | $17.28M derived: sum of 3 quarters · filed 2020-03-16 | $23.87M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | $4.15M 10-Q · filed 2019-05-09 | $11.66M derived: sum of 2 quarters · filed 2020-03-16 | $18.25M derived: sum of 3 quarters · filed 2020-03-16 | $27.94M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2017-12-31 | $7.51M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $14.10M derived: sum of 2 quarters · filed 2020-03-16 | $23.79M derived: sum of 3 quarters · filed 2020-03-16 | $34.06M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $6.59M 10-Q · filed 2018-10-31 | $16.28M derived: sum of 2 quarters · filed 2018-10-31 | $26.55M 10-Q · filed 2018-10-31 | $42.99M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-06-30 | $9.69M 10-Q · filed 2018-08-09 | $19.96M 10-Q · filed 2018-08-09 | $36.40M derived: sum of 3 quarters · filed 2019-03-15 | $48.86M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-03-31 | $10.27M 10-Q · filed 2018-05-08 | $26.71M derived: sum of 2 quarters · filed 2019-03-15 | $39.17M derived: sum of 3 quarters · filed 2019-03-15 | $52.79M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2016-12-31 | $16.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | $28.90M derived: sum of 2 quarters · filed 2019-03-15 | $42.52M derived: sum of 3 quarters · filed 2019-03-15 | $52.76M 10-K/A · filed 2019-03-15 | |
| 2016-09-30 | $12.46M 10-Q · filed 2017-11-09 | $26.07M derived: sum of 2 quarters · filed 2017-11-09 | $36.32M 10-Q · filed 2017-11-09 | $48.39M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $13.62M 10-Q · filed 2017-08-08 | $23.86M 10-Q · filed 2017-08-08 | $35.93M derived: sum of 3 quarters · filed 2018-03-16 | $46.75M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $10.25M 10-Q · filed 2017-05-10 | $22.32M derived: sum of 2 quarters · filed 2018-03-16 | $33.13M derived: sum of 3 quarters · filed 2018-03-16 | $39.55M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $12.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $22.89M derived: sum of 2 quarters · filed 2018-03-16 | $29.31M derived: sum of 3 quarters · filed 2018-03-16 | $37.51M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $10.81M 10-Q · filed 2016-11-14 | $17.23M derived: sum of 2 quarters · filed 2016-11-14 | $25.44M 10-Q · filed 2016-11-14 | $31.83M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-06-30 | $6.42M 10-Q · filed 2016-08-12 | $14.63M 10-Q · filed 2016-08-12 | $21.02M derived: sum of 3 quarters · filed 2017-03-16 | $28.00M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-03-31 | $8.21M 10-Q · filed 2016-05-13 | $14.59M derived: sum of 2 quarters · filed 2017-03-16 | $21.57M derived: sum of 3 quarters · filed 2017-03-16 | $25.48M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-12-31 | $6.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $13.37M derived: sum of 2 quarters · filed 2017-03-16 | $17.27M derived: sum of 3 quarters · filed 2017-03-16 | $21.78M 10-K · filed 2017-03-16 | |
| 2014-09-30 | $6.98M 10-Q · filed 2015-11-13 | $10.88M derived: sum of 2 quarters · filed 2015-11-13 | $15.39M 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $3.90M 10-Q · filed 2015-08-14 | $8.41M 10-Q · filed 2015-08-14 | |||
| 2014-03-31 | $4.50M 10-Q · filed 2015-06-18 | ||||
| 2013-12-31 | $9.93M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |